Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Ordinary shares
-
Shares outstanding
-
49,942,911
-
Total 13F shares
-
43,068,701
-
Share change
-
+1,862,436
-
Total reported value
-
$1,459,854,294
-
Put/Call ratio
-
69%
-
Price per share
-
$33.89
-
Number of holders
-
135
-
Value change
-
-$99,787,937
-
Number of buys
-
80
-
Number of sells
-
69
Institutional Holders of Immunocore Holdings plc - Ordinary shares (IMCR) as of Q2 2024
As of 30 Jun 2024,
Immunocore Holdings plc - Ordinary shares (IMCR) was held by
135 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,068,701 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, RTW INVESTMENTS, LP, FMR LLC, T. Rowe Price Investment Management, Inc., PRICE T ROWE ASSOCIATES INC /MD/, PRIMECAP MANAGEMENT CO/CA/, BAKER BROS. ADVISORS LP, GENERAL ATLANTIC, L.P., Bellevue Group AG, and ARMISTICE CAPITAL, LLC.
This page lists
135
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.